CVRx

CVRx designs implantable neuromodulation devices to treat heart failure and hypertension, notably through its Barostim therapy. The company's technology uses electrical impulses to improve cardiovascular function and reduce hospitalizations. CVRx is recognized for its impact on chronic disease management and real-world evidence supporting its devices.

Company Facts

• Headquarters: New York, United States
• Type: private equity
• Website: https://www.cvrx.com
• Industries: Technology, Software, Services